Actively Recruiting
Race-Based Stress and Cognitive Training for MCI
Led by Rosalind Franklin University of Medicine and Science · Updated on 2025-07-24
9
Participants Needed
1
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group. Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group. Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.
CONDITIONS
Official Title
Race-Based Stress and Cognitive Training for MCI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be able to attend in-person sessions at Rosalind Franklin University
- Must self-identify as Black/African American or as Black/African American along with another racial/ethnic group
- May include participants who identify as Hispanic/Latine
- Must be at least 65 years old
- Must have mild cognitive impairment or self-reported cognitive difficulties
You will not qualify if you...
- Diagnosis of dementia or major neurocognitive disorder
- Intellectual disability
- Mild head injury or concussion within the last six months
- History of moderate to severe traumatic brain injury
- Cognitive assessment scores indicating dementia level (less than 2 standard deviations below mean on RBANS)
- Not at least 65 years old or without mild cognitive impairment or cognitive difficulties
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rosalind Franklin University of Medicine and Science
Chicago, Illinois, United States, 60064
Actively Recruiting
Research Team
R
Rachael L Ellison, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here